Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jay Wish

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Journal of Medical Economics|May 5, 2010
Burden of illness for patients with non-dialysis chronic kidney disease and anemia in the United States: review of the literatureFloortje E van Nooten, Julia Green, Ruth Brown, et al.
Plos One|December 21, 2013
Recovery of renal function among ESRD patients in the US medicare programSumit Mohan, Edwin Huff, Jay Wish, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|June 30, 2016
A comparison between physicians and computer algorithms for form CMS-2728 data reportingMohammed Said Malas, Jay Wish, Ranjani Moorthi, et al.
Frontiers in Pharmacology|January 29, 2019
Erythropoiesis-Stimulating Agents in the Management of Anemia in Chronic Kidney Disease or Cancer: A Historical PerspectiveMatti Aapro, Pere Gascón, Kashyap Patel, et al.
Critical Reviews in Oncology/Hematology|August 12, 2018
A quick scoping review of efficacy, safety, economic, and health-related quality-of-life outcomes of short- and long-acting erythropoiesis-stimulating agents in the treatment of chemotherapy-induced anemia and chronic kidney disease anemiaLuiz H Arantes, Jeffrey Crawford, Pere Gascon, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 7, 2026
KDOQI US Commentary on the KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in CKDDiana I Jalal, Nisha Bansal, Monique E Cho, et al.
Journal of Clinical Medicine|July 29, 2025
Evaluating the Risk of Hypophosphatemia with Ferric Carboxymaltose and the Recommended Approaches for Management: A Consensus StatementGiuseppe Rosano, Justin Ezekowitz, Elizabeta Nemeth, et al.
Kidney International Reports|October 27, 2025
"<i>Inside CKD</i>" Multinational-Microsimulation Modelling Insights Into the Increasing CKD BurdenJay Wish, Saeed Mg Al-Ghamdi, Jean-Michel Halimi, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 14, 2002
Regional variability in anaemia management and haemoglobin in the USDonal N Reddan, Diane L Frankenfield, Preston S Klassen, et al.
Seminars in Dialysis|October 6, 2004
Improving outcomes in CKD and ESRD patients: carrying the torch from training to practiceAllen R Nissenson, Rajiv Agarwal, Michael Allon, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of Medical Economics|May 5, 2010
Burden of illness for patients with non-dialysis chronic kidney disease and anemia in the United States: review of the literatureFloortje E van Nooten, Julia Green, Ruth Brown, et al.
Plos One|December 21, 2013
Recovery of renal function among ESRD patients in the US medicare programSumit Mohan, Edwin Huff, Jay Wish, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|June 30, 2016
A comparison between physicians and computer algorithms for form CMS-2728 data reportingMohammed Said Malas, Jay Wish, Ranjani Moorthi, et al.
Frontiers in Pharmacology|January 29, 2019
Erythropoiesis-Stimulating Agents in the Management of Anemia in Chronic Kidney Disease or Cancer: A Historical PerspectiveMatti Aapro, Pere Gascón, Kashyap Patel, et al.
Critical Reviews in Oncology/Hematology|August 12, 2018
A quick scoping review of efficacy, safety, economic, and health-related quality-of-life outcomes of short- and long-acting erythropoiesis-stimulating agents in the treatment of chemotherapy-induced anemia and chronic kidney disease anemiaLuiz H Arantes, Jeffrey Crawford, Pere Gascon, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 7, 2026
KDOQI US Commentary on the KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in CKDDiana I Jalal, Nisha Bansal, Monique E Cho, et al.
Journal of Clinical Medicine|July 29, 2025
Evaluating the Risk of Hypophosphatemia with Ferric Carboxymaltose and the Recommended Approaches for Management: A Consensus StatementGiuseppe Rosano, Justin Ezekowitz, Elizabeta Nemeth, et al.
Kidney International Reports|October 27, 2025
"<i>Inside CKD</i>" Multinational-Microsimulation Modelling Insights Into the Increasing CKD BurdenJay Wish, Saeed Mg Al-Ghamdi, Jean-Michel Halimi, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 14, 2002
Regional variability in anaemia management and haemoglobin in the USDonal N Reddan, Diane L Frankenfield, Preston S Klassen, et al.
Seminars in Dialysis|October 6, 2004
Improving outcomes in CKD and ESRD patients: carrying the torch from training to practiceAllen R Nissenson, Rajiv Agarwal, Michael Allon, et al.
Pageof 2